Skip to main content

Chorioretinal Degeneration clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Gyrate Atrophy Ocular and Systemic Study

    Sorry, not yet accepting patients

    The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration.

    San Francisco, California and other locations

Our lead scientists for Chorioretinal Degeneration research studies include .

Last updated: